Feline Chlamydiosis: The Hidden Cause of the Watery, Red Eye
- Dr Andrew Matole, BVetMed, MSc
- Jun 8
- 10 min read
A small, stealthy bacterium that lives only inside the cells of a cat’s conjunctiva is one of the most common — and most treatable — causes of persistent eye disease "flu" in kittens. Here is what every owner and clinician should know.
Few presentations in feline practice are as familiar – or as frequently misread – as the young cat with a weepy, half-closed, reddened eye. Owners often assume their kitten has been scratched or has “something in the eye". In a large proportion of these cases, the true culprit is a bacterium that cannot survive for more than a few minutes outside its host yet sets up shop with remarkable persistence inside the delicate lining of the eye: Chlamydia felis.
Feline chlamydiosis is the disease caused by infection with this organism. It is a leading infectious cause of conjunctivitis in cats, and although it can look alarming, it responds beautifully to prompt, correct treatment (Gruffydd-Jones et al., 2009). The challenge lies in recognising it, distinguishing it from the viral causes of cat "flu", and treating it for long enough to truly clear the infection rather than merely silencing the signs.
A bacterium that lives only inside cells
Chlamydia felis is a Gram-negative, obligate intracellular bacterium — meaning it is biologically incapable of multiplying on its own and must hijack the machinery of a living host cell to reproduce. Its preferred home is the epithelium of the conjunctiva, the pink membrane lining the eyelids and covering the white of the eye (Gruffydd-Jones et al., 2009). Because the organism dies almost immediately in the environment, transmission depends on close, direct contact between cats rather than on contaminated surfaces (ABCD, 2024).
A point of frequent confusion is the name. For years, the organism was called Chlamydophila felis. A 2015 revision of bacterial taxonomy collapsed the family back into a single genus, so the current, correct name is once again Chlamydia felis (Sachse et al., 2015). Older textbooks and laboratory reports may still use the previous term; they refer to the same organism.
Clinical pearl - Respiratory signs are usually minimal with C. felis. A cat with sneezing and nasal discharge but no ocular involvement is unlikely to have chlamydiosis — look harder at feline herpesvirus and calicivirus instead (ABCD, 2024).
The Biology: A Two-Form Life Cycle
To understand why chlamydiosis must be treated for several weeks — and why a few days of antibiotics are never enough — it helps to picture how the organism actually lives. Chlamydia alternates between two distinct forms in a tightly choreographed developmental cycle (AbdelRahman & Belland, 2005).
The elementary body (EB) is the tough, infectious, “spore-like” form of certain intracellular pathogens, particularly well-known in the context of Chlamydia species. This form is characterised by its resilience and ability to withstand harsh environmental conditions, making it highly effective for transmission. The EB is metabolically quiet, meaning it does not engage in significant metabolic activity while outside of a host cell. Its primary role is to facilitate the spread of the infection by travelling between cells and from one cat to another, thereby ensuring the continuation of the infection cycle. The structure of the EB is designed to protect its genetic material and proteins from degradation, allowing it to remain viable during its journey through various environments, including the external environment and within the host's body.
The reticulate body (RB) is the fragile, metabolically active form that emerges once the elementary body has successfully infiltrated a host cell. This transformation is crucial for the pathogen's lifecycle. The RB resides within a specialised compartment known as the inclusion, which is a membrane-bound structure that provides a protected environment for the RB. Inside this inclusion, the RB undergoes rapid replication and growth, utilising the host cell's resources to multiply. The RB is less durable than the EB, reflecting its active role in the infection process, as it engages in metabolic activities essential for the synthesis of proteins and other cellular components required for its proliferation. This phase is critical, as the RBs will eventually revert to EBs to facilitate the spread of the infection to new host cells, thereby continuing the cycle of infection.
Figure 3
⚡ “The organism that causes so much misery is helpless on its own — it can only borrow life, one cell at a time.”
Pathophysiology: How a Microbe Becomes a Disease
Because C. felis lives inside cells, its biology dictates the symptoms, the chronicity and the rules of treatment all at once. The story unfolds in four overlapping acts.
1 · Entry, and a protective bubble
An elementary body attaches to a conjunctival epithelial cell and is drawn inside within a membrane-bound vacuole. Ordinarily, the cell would fuse that vacuole with a lysosome and digest whatever is inside. Chlamydia subverts this defence: it remodels the vacuole into a specialised compartment — the inclusion — and steers it away from the destructive lysosomal pathway, in effect hiding in plain sight within the cell (Elwell et al., 2016).
2 · Hijacking the host cell
From within the inclusion, the bacterium secretes an arsenal of effector proteins that reprogram the host cell — diverting its lipids and nutrients to feed the growing colony and even suppressing the cell’s own “self-destruct” (apoptosis) programme so the infected cell stays alive long enough to serve as a replication factory (Elwell et al., 2016)
3 · Inflammation — the signs you actually see
Crucially, the redness, the jelly-like chemosis, the squinting and the discharge are not produced directly by the bacterium. They are the host’s inflammatory response to infection. Infected and dying epithelial cells release signals that recruit inflammatory cells and dilate the conjunctival blood vessels, producing the hyperaemia, swelling and ocular discomfort that define the clinical picture (Sykes, 2005). In other words, the disease is a conversation between microbe and immune system — and the eye is where that conversation becomes visible.
4 · Persistence — the relapse trap
Under pressure — immune signals such as interferon-gamma, nutrient restriction, stress, or an incomplete course of antibiotics — chlamydiae can switch into a dormant, “persistent” state. The reticulate bodies swell into enlarged, non-dividing aberrant bodies that stop producing infectious progeny yet are not killed. When the pressure lifts, they can resume the normal cycle, and the disease flares again (Hogan et al., 2004). This one phenomenon explains two of this article’s most important practical messages: why treatment must outlast the visible signs, and why reducing stress and overcrowding matters almost as much as the antibiotic itself.
⚡Why the course must outlast the cure - Because persistent forms survive immune pressure and short antibiotic courses only to reawaken later, a few days of treatment can convert a tidy acute infection into a smouldering, relapsing one. Completing the full multi-week course — and keeping the cat calm and uncrowded — is what closes that escape route (Hogan et al., 2004).
How cats catch it
Because C. felis cannot persist in the environment, spread is overwhelmingly through close contact – mutual grooming, shared sleeping spaces, and direct exposure to ocular and nasal secretions (ABCD, 2024). The incubation period is short — usually a few days to about two weeks from exposure to the first signs. This is why chlamydiosis behaves as a problem of density: it is far more common in multi-cat households, breeding catteries, rescue shelters and feral colonies than in singly housed pets (Helps et al., 2005).
What Chlamydiosis Looks Like
The hallmark of feline chlamydiosis is conjunctivitis. Classically it begins in one eye and spreads to the second within a week or so. The conjunctiva becomes intensely reddened, and one of the most characteristic findings is chemosis — a marked, almost jelly-like swelling of the conjunctiva that can bulge between the eyelids (Sykes, 2005). Affected cats squint (blepharospasm), and a discharge develops that is watery at first and later mucopurulent.
Onset - Unilateral, becoming bilateral over days
Conjunctiva – Marked redness; chemosis (swelling)
Discomfort - Squinting & blepharospasm
Discharge - Watery → mucopurulent
Age – Mainly cats under 9 months
Cornea – Usually spared → ulcers point to herpes virus
Most cats remain bright and continue to eat, although a transient fever, mild lethargy and inappetence can occur shortly after infection (Gruffydd-Jones et al., 2009). A crucial diagnostic clue is what is usually absent: significant corneal involvement. Keratitis and corneal ulcers are not typical of chlamydiosis, and when present, they point far more strongly toward feline herpesvirus (ABCD, 2024). Left untreated, the conjunctivitis can grumble on for weeks or even months.
⚡Don’t confuse it with cat flu - Feline herpesvirus and calicivirus also cause eye and respiratory signs. The pattern that favours C. felis is conjunctivitis dominant, respiratory signs mild, cornea clear. Because mixed infections are common in catteries, laboratory confirmation is invaluable (Helps et al., 2005).
Confirming the diagnosis
Clinical suspicion is a good start, but because several pathogens produce similar-looking eyes, confirmation matters. The modern method of choice is PCR performed on a conjunctival (or oropharyngeal) swab, which detects the organism’s DNA with high sensitivity and specificity (Gruffydd-Jones et al., 2009). Swabs should be taken before applying any topical treatment, and ideally a multiplex panel is used so that herpesvirus, calicivirus and C. felis can be distinguished in one test.
Cytology of conjunctival scrapings may reveal the characteristic intracytoplasmic inclusion bodies, particularly early in the disease, but it is far less sensitive than PCR. Older antigen-detection (ELISA) tests and antibody serology have largely been superseded, although serology can still be informative in unvaccinated cats (Sykes, 2005). Quantitative PCR has the additional advantage that it can be used to monitor whether treatment is genuinely clearing the organism (Dean et al., 2005).
Treatment: the right drug, for long enough
Here is the good news that every worried owner wants to hear: chlamydiosis responds rapidly to appropriate antibiotics, with ocular signs often visibly improving within 48 hours of starting treatment (ABCD, 2024). The tetracyclines are the drugs of choice, and oral doxycycline is the standard, given once daily — commonly at around 10 mg/kg — because it penetrates well into the very cells where the organism shelters (Gruffydd-Jones et al., 2009). For very young kittens or where doxycycline is unsuitable, amoxicillin-clavulanate is an effective alternative (ABCD, 2024).
The single most important — and most commonly mishandled — principle is duration. Because of the multi-stage life cycle described above, signs disappear long before the organism is eradicated. Treatment should continue for at least four weeks and for a minimum of two weeks beyond the resolution of all clinical signs (Sparkes et al., 1999). Stopping early is the classic route to relapse. Equally important: in multi-cat settings, every in-contact cat should be treated, not just the symptomatic one, because subclinical carriers will otherwise re-seed the household.
Beyond the core antibiotic, treatment is rounded out by supportive measures. Topical tetracycline or chloramphenicol eye ointments may be used alongside the systemic course to ease ocular signs, but they are an adjunct to systemic therapy — never a replacement for it. Good hydration and nutrition aid recovery, and because stress and overcrowding can precipitate flare-ups of a persistent infection, easing both is a genuine part of the treatment plan rather than an afterthought (Hogan et al., 2004).
Prevention and vaccination
A vaccine against C. felis exists, but it is a non-core vaccine — not recommended for every cat. Importantly, it reduces the severity of disease rather than fully preventing infection or shedding, so it is best reserved for cats at genuine, ongoing risk: those entering or living in breeding catteries and shelters or households with a confirmed history of chlamydiosis (ABCD, 2024). Where vaccination is used, the primary course typically begins at around 8–10 weeks of age with a second dose three to four weeks later, followed by boosters for cats that remain at risk (Gruffydd-Jones et al., 2009).
For most owners, the practical pillars of prevention are unglamorous but effective: quarantine and examine new arrivals, reduce overcrowding, maintain good hygiene, and treat outbreaks thoroughly the first time so they do not become entrenched.
Can People Catch It?
The zoonotic risk is low but not zero. Rare, well-documented cases of C. felis conjunctivitis in humans — usually in people in very close contact with infected cats — have been reported in the medical literature (Wons et al., 2017). Sensible, simple hygiene is the answer: wash your hands after handling an infected cat or medicating its eyes, and avoid touching your own eyes in between. People who are immunocompromised should be especially careful. For context, occasional reports have also identified other chlamydial species in cats with conjunctivitis, underlining the value of laboratory confirmation in unusual or non-responsive cases (Sibitz et al., 2011).
⚡ The bottom line for owners - A young cat with a red, weepy, swollen eye that started in one eye deserves a veterinary visit — not a wait-and-see approach. Chlamydiosis is common, confirmable and very treatable, but it rewards early, complete, whole-household treatment. If your cat’s eye is sore, painful, or not improving, please have it examined.
If you are in Nairobi and your cat is showing any of the signs described here, our team is happy to examine the eye, take the appropriate swabs and start the right course of treatment. Catching chlamydiosis early makes the difference between a tidy four-week cure and months of frustration.
References
AbdelRahman YM, Belland RJ (2005). The chlamydial developmental cycle. FEMS Microbiology Reviews, 29(5), 949–959.
Dean R, Harley R, Helps C, Caney S, Gruffydd-Jones T (2005). Use of quantitative real-time PCR to monitor the response of Chlamydophila felis infection to doxycycline treatment. Journal of Clinical Microbiology, 43(4), 1858–1864.
European Advisory Board on Cat Diseases (ABCD) (2024). Guideline for Chlamydia felis. abcdcatsvets.org (updated November 2024).
Gruffydd-Jones T, Addie D, Belák S, et al. (2009). Chlamydophila felis infection: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), 605–609.
Helps CR, Lait P, Damhuis A, et al. (2005). Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Veterinary Record, 156(21), 669–673.
Sachse K, Bavoil PM, Kaltenboeck B, et al. (2015). Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species. Systematic and Applied Microbiology, 38(2), 99–103.
Sparkes AH, Caney SM, Sturgess CP, Gruffydd-Jones TJ (1999). The clinical efficacy of topical and systemic therapy for the treatment of feline ocular chlamydiosis. Journal of Feline Medicine and Surgery, 1(1), 31–35.
Sykes JE (2005). Feline chlamydiosis. Clinical Techniques in Small Animal Practice, 20(2), 129–134.
Wons J, Meiller R, Bergua A, Bogdan C, Geißdörfer W (2017). Follicular conjunctivitis due to Chlamydia felis – case report, review of the literature and improved molecular diagnostics. Frontiers in Medicine, 4, 105.
Sibitz C, Rudnay EC, Wabnegger L, Spergser J, Apfalter P, Nell B (2011). Detection of Chlamydophila pneumoniae in cats with conjunctivitis. Veterinary Ophthalmology, 14 (Suppl 1), 67–74.
Elwell C, Mirrashidi K, Engel J (2016). Chlamydia cell biology and pathogenesis. Nature Reviews Microbiology, 14(6), 385–400.
Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P (2004). Chlamydial persistence: beyond the biphasic paradigm. Infection and Immunity, 72(4), 1843–1855.
Comments